Clinical Trial Update: The Effect of Magnesium Oxide on Plasma Phosphate in Hemodialysis Patients

View source ↗

Summary

A completed clinical trial evaluated the effect of magnesium oxide on plasma phosphate levels in hemodialysis patients with hyperphosphatemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperphosphatemia

Drugs mentioned

• Magnesium oxide (magnesium oxide)

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: Hyperphosphatemia | Status: COMPLETED